Public health, innovation, intellectual property and trade

Monitoring and reporting

PHI’s role in monitoring and reporting of GSPA-PHI

  • Setting up reporting mechanisms for Member Sates and other stakeholders
  • Providing technical assistance to Member States for collection of data
  • Reporting to WHO governing bodies on the overall implementation of the strategy

One of the elements of the GSPA-PHI (element 8) states that: “Systems should be established to monitor performance and progress of this strategy. A progress report will be submitted to the Health Assembly through the Executive Board every two years. A comprehensive evaluation of the strategy will be undertaken after four years”.

Additionally, action (8.1) establishes that measuring performance and progress towards objectives contained in the GSPA should include the following activities:

  • Establish systems to monitor performance and progress of the implementation of each element of the GSPA.

PHI has developed a web-based platform on innovation and access following the structure of the GSPA-PHI. This platform offers a password-protected environment where governments can store, analyse and share information on their national innovation system, mapped using the assessment tool provided below.

An example of a published assessment is the one conducted in Sri Lanka, full report available below.



Public health, innovation, intellectual property and trade

Dr Suzanne Hill
Director, EMP
Essential Medicines and Health Products (EMP)

Dr Marie-Paule Kieny
Assistant Director-General, HIS
Health Systems and Innovation (HIS)